BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chinchilla-lópez P, Qi X, Yoshida EM, Méndez-sánchez N. The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma. Annals of Hepatology 2017;16:328-30. [DOI: 10.5604/01.3001.0009.8585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Gravier-Hernández R, Gil-Del Valle L, Valdes-Alonso L, Hernández-Ayala N, Bermúdez-Alfonso Y, Hernández-Requejo D, Rosell-Guerra T, Hernández-González-Abreu MC. Oxidative stress in hepatitis C virus-human immunodeficiency virus co-infected patients. Ann Hepatol 2020;19:92-8. [PMID: 31607646 DOI: 10.1016/j.aohep.2019.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
2 Jia C, Yao Z, Lin Z, Zhao L, Cai X, Chen S, Deng M, Zhang Q. circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression. J Cell Physiol 2021;236:1252-69. [PMID: 32667692 DOI: 10.1002/jcp.29931] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]